The Cromer blood group system: a review
By:
Paid access
|Mar 2020References
- McCormick EE, Francis BJ, Gelb AB. A new antibody apparently defining an allele of Goa (abstract). Transfusion 1965;5:369–70
- Stroup M, McCreary J. Cra, another high frequency blood group factor (abstract). Transfusion 1975;15:522.
- Daniels GL, Tohyama H, Uchikawa M. A possible null phenotype in the Cromer blood group complex. Transfusion 1982;22:362–3.
- Yazer MH, Judd WJ, Davenport RD, et al. Case report and literature review: transient Inab phenotype and an agglutinating anti-IFC in a patient with a gastrointestinal problem. Transfusion 2006;46:1537–42.
- Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307–13.
- Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993–8.
- Parsons SF, Spring FA, Merry AH. Evidence that Cromer-related blood group antigens are carried on decay accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency (abstract). In: Proceedings of the XXth Congress of the International Society of Blood Transfusion. London: British Blood Transfusion Society, 1988:116.
- Lublin DM, Atkinson JP. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol 1989;7:35–58.
- Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. Leucocyte antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 1997.
- Rey-Campos J, Rubinstein P, Rodriguez de Cordoba S. Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J Exp Med 1987;166:246–52.
- Medof ME, Lublin DM, Holers VM, et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A 1987;84:2007–11.
- Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987;325:545–9.
- Post TW, Arce MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM. Structure of the gene for human complement protein decay accelerating factor. J Immunol 1990;144:740–4.
- Laird-Fryer B, Dukes CV, Lawson J, Moulds JJ, Walker EM Jr, Glassman AB. Tca: A high-frequency blood group antigen. Transfusion 1983;23:124–7.
- Levene C, Harel N, Lavie G, Greenberg S, Laird-Fryer B, Daniels GL. A “new” phenotype confirming a relationship between Cra and Tca. Transfusion 1984;24:13–15.
- Tregellas WM. Description of a new blood group antigen, Esa (abstract). In: 18th Congress of the International Society of Blood Transfusion, Paris, 1984:163.
- Daniels G, Walthers L. Anti-IFC, an antibody made by Inab phenotype individuals. Transfusion 1986;26:117–18.
- Petty AC, Daniels GL, Tippett P. Provisional assignment of Cromer system antigens to the short consensus repeats of decay accelerating factor (CD 55) (abstract). Transfusion 1993;33(Suppl):46S.
- Hue-Roye K, Lomas-Francis C, Belaygorod L, et al. Three new high-prevalence antigens in the Cromer blood group system. Transfusion 2007;47:1621–9.
- Lublin DM, Kompelli S, Storry JR, Reid ME. Molecular basis of Cromer blood group antigens. Transfusion 2000;40:208–13.
- Telen MJ, Rao N, Lublin DM. Location of WESb on decay-accelerating factor (letter). Transfusion 1995;35:278.
- Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84:3205–11.
- Smith KJ, Coonce LS, South SF, Troup GM. Anti-Cra: family study and survival of chromium-labeled incompatible red cells in a Spanish-American patient. Transfusion 1983;23:167–9.
- Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science, 2002.
- Sacks DA, Garratty G. Isoimmunization to Cromer antigen in pregnancy. Am J Obstet Gynecol 1989;161:928–9.
- Laird-Fryer B, Dukes C, Walker EM Jr, Glassman A, Moulds JJ. Tca: a new high-incidence blood group factor (abstract). Transfusion 1980;20:631.
- Block U, Lacey P, Moulds J, Bryant L, Giandelone A, Linnemeyer D. Anti-Tcb: An antibody defining a low-incidence antigen allelic to Tca (abstract). Transfusion 1982;22:413.
- Lacey PA, Block UT, Laird-Fryer BJ, et al. Anti-Tcb, an antibody that defines a red cell antigen antithetical to Tca. Transfusion 1985;25:373–6.
- Law J, Judge A, Covert P, Lewis N, Sabo B, McCreary M. A new low-frequency factor proposed to be the product of an allele to Tca (abstract). Transfusion 1982;22:413.
- Levene C, Harel N, Kende G, Papo S, Bradford MF, Daniels GL. A second Dr(a–) proposita with anti-Dra and a family with the Dr(a–) phenotype in two generations. Transfusion 1987;27:64–5.
- Daniels G. Cromer-related antigens—blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205–11.
- Reid ME, Mallinson G, Sim RB, et al. Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 1991;78:3291–7.
- Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276–82.
- Daniels GL, Green CA, Mallinson G, et al. Decay-accelerating factor (CD55) deficiency phenotypes in Japanese. Transfus Med 1998;8:141–7.
- Uchikawa M, Tsuneyama H, Wang L, et al. Rare Cromer blood group phenotypes detected in Japanese (abstract). In: 24th Congress of the International Society of Blood Transfusion (ISBT), Makuhari Messe, Japan, 1996;143.
- Lublin DM, Thompson ES, Green AM, Levene C, Telen MJ. Dr(a–) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J Clin Invest 1991;87:1945–52.
- Nowicki B, Moulds J, Hull R, Hull S. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun 1988;56:1057–60.
- Reid ME, Marfoe RA, Mueller AL, Arndt PA, Sausais L, Spruell P. A second example of anti-Esa, an antibody to a high-incidence Cromer antigen. Immunohematology 1996;12:112–14.
- Wang L, Uchiwawa M, Tsuneyama H, Tokunaga K, Tadokoro K, Juji T. Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype. Blood 1998;91:680–4.
- Uchikawa M, Tsuneyama H, Ogasawara K, et al. Another example of Inab phenotype in Japanese and production of human monoclonal anti-DAF (abstract). Vox Sang 2004;87(S3):41.
- Hue-Roye K, Powell VI, Patel G, et al. Novel molecular basis of an Inab phenotype. Immunohematology 2005;21:53–5.
- Walthers L, Salem M, Tessel J, Laird-Fryer B, Moulds JJ. The Inab phenotype: another example found (abstract). Transfusion 1983;23:423.
- Lin RC, Herman J, Henry L, Daniels GL. A family showing inheritance of the Inab phenotype. Transfusion 1988;28:427–9.
- Daniels GL. Blood group antigens of high frequency: a serological and genetical study (thesis). London: MRC Blood Group Unit, University College, 1980.
- Rosse WF, Hoffman S, Campbell M, Borowitz M, Moore JO, Parker CJ. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Br J Haematol 1991;79:99–107.
- Merry AH, Rawlinson VI, Uchikawa M, Daha MR, Sim RB. Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor). Br J Haematol 1989;73:248–53.
- Rosse WF. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 1990;75:1595–601.
- Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 1987;165:848–64.
- Matthes T, Tullen E, Poole J, et al. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC. Transfusion 2002;42:1448–57.
- Banks J, Poole J, Prowse C, Warke N, Ekermo B, Hilden J-O. Transient loss of Cromer antigens and anti-IFC in a patient with chronic lymphatic leukemia. Vox Sang 2004;87(S3):37.
- Sistonen P, Nevanlinna HR, Virtaranta-Knowles K, et al. WES, a ‘new’ infrequent blood group antigen in Finns. Vox Sang 1987;52:111–14.
- Copeland TR, Smith JH, Wheeling RM, Rudolph MG. The incidence of WESa in 3,072 donors in the United States. Immunohematology 1991;7:76–7.
- Daniels GL, Green CA, Darr FW, Anderson H, Sistonen P. A ‘new’ Cromer-related high frequency antigen probably antithetical to WES. Vox Sang 1987;53:235–8.
- Daniels GL, Okubo Y, Yamaguchi H, Seno T, Ikuta M. UMC, another Cromer-related blood group antigen. Transfusion 1989;29:794–7.
- Storry JR, Sausais L, Hue-Roye K, et al. GUTI: a new antigen in the Cromer blood group system. Transfusion.2003;43:340–4.
- Banks J, Poole J, Ahrens N, et al. SERF: a new antigen in the Cromer blood group system. Transfus Med 2004;14:313–18.
- Palacajornsuk P, Hue-Roye K, Nathalang O, Tantimavanich S, Bejrachandra S, Reid ME. Analysis of SERF in Thai blood donors. Immunohematology 2005;21:66–9.
- Reid ME, Green CA, Hoffer J, Øyen R. Effect of pronase on high-incidence blood group antigens and the prevalence of antibodies to pronase-treated erythrocytes. Immunohematology 1996;12:139–42.
- Judd WJ, Steiner EA, Miske V. Adsorption of anti-Cra by human platelet concentrates (letter). Transfusion 1991;31:286.
- Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of the erythrocyte. New York, NY: AR Liss, 1980:305–23.
- Garratty G, Nance SJ. Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry. Transfusion 1990;30:617–21.
- McSwain B, Robins C. A clinically significant anti-Cra. Transfusion 1988;28:289–90.
- Gorman MI, Glidden HM, Behzad O. Another example of anti-Tca (abstract). Transfusion 1981;21:579.
- Ross DG, McCall L. Transfusion significance of anti-Cra (letter). Transfusion 1985;25:84.
- Anderson G, Gray LS, Mintz PD. 51 Cr-radiolabeled red cell survival in a patient with anti-Tca (abstract). Transfusion 1987;27:546.
- Whitsett CF, Oxendine SM. Survival studies with another example of anti-Cra. Transfusion 1991;31:782–4.
- Kowalski MA, Pierce SR, Edwards RL, Ethirajan S, Ryan K, Livergood MP. Hemolytic transfusion reaction due to anti-Tca. Transfusion 1999;39:948–50.
- Reid ME, Ellisor SS, Dean WD. Elution of anti-Cra. Superiority of the digitonin-acid elution method. Transfusion 1985;25:172–3.
- Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099–105.
- Weber SL, Bryant BJ, Indrikovs AJ. Sequestration of anti-Cra in the placenta: serologic demonstration by placental elution. Transfusion 2005;45:1327–30.
- Reid ME, Chandrasekaran V, Sausais L, Pierre J, Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996;71:48–50.
- Dickson AC, Guest C, Jordon M, Banks J, Kumpel BM. Case report: anti-Cra in pregnancy. Immunohematology 1995;11:14–17.
- Rahimi-Levene N, Kornberg A, Siegel G, et al. Persistent anti-Dra in two pregnancies. Immunohematology 2005;21:126–8.
DOI: https://doi.org/10.21307/immunohematology-2019-210 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 109 - 117
Published on: Mar 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2020 J.R. Storry, M.E. Reid, M.H. Yazer, published by American National Red Cross
This work is licensed under the Creative Commons License.